TG Therapeutics, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for TG Therapeutics, Inc. (TGTX) is 18.61

According to TG Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 18.61. This represents a change of -52.47% compared to the average of 39.15 of the last 4 quarters.

TG Therapeutics, Inc. (TGTX) Historical PE Ratio (quarterly & annually)

How has TGTX PE Ratio performed in the past?

The mean historical PE Ratio of TG Therapeutics, Inc. over the last ten years is 33.75. The current 18.61 PE Ratio has changed 5.41% with respect to the historical average. Over the past ten years (40 quarters), TGTX's PE Ratio was at its highest in in the March 2025 quarter at 285.72. The PE Ratio was at its lowest in in the March 2024 quarter at -50.44.

TG Therapeutics, Inc. (TGTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of TG Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TG Therapeutics, Inc. (TGTX) Average PE Ratio

How has TGTX PE Ratio performed in the past?

The current PE Ratio of TG Therapeutics, Inc. (TGTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TG Therapeutics, Inc. (TGTX) PE Ratio vs. Peers

How is TGTX’s PE Ratio compared to its peers?

TG Therapeutics, Inc.’s PE Ratio is greater than PTC Therapeutics, Inc. (-33.84), greater than Arrowhead Pharmaceuticals, Inc. (-38.23), greater than Protagonist Therapeutics, Inc. (-62.63), less than Krystal Biotech, Inc. (44.91), greater than CRISPR Therapeutics AG (-8.70), greater than Vaxcyte, Inc. (-7.47), less than Alkermes plc (48.38), greater than Arcellx, Inc. (-28.27), greater than Immunovant, Inc. (-12.71), greater than Kymera Therapeutics, Inc. (-25.26),

Build a custom stock screener for TG Therapeutics, Inc. (TGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TG Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TG Therapeutics, Inc. (TGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TG Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.